Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
57
|
501
|
0.400 |
None |
0.945 |
2 |
|
1978 |
2020 |
Arthritis, Psoriatic
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
14
|
44
|
0.400 |
None |
0.907 |
1 |
1
|
1991 |
2019 |
HIV Infections
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
103
|
95
|
0.400 |
None |
0.933 |
0 |
1
|
1998 |
2018 |
Toxic Epidermal Necrolysis
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
29
|
14
|
0.390 |
None |
1.000 |
1 |
1
|
2009 |
2019 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
883
|
1629
|
0.380 |
None |
1.000 |
2 |
1
|
1993 |
2018 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
87
|
97
|
0.360 |
None |
1.000 |
1 |
|
1996 |
2020 |
Hepatitis B, Chronic
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
8
|
19
|
0.330 |
None |
1.000 |
1 |
|
2010 |
2016 |
Pustulosis of Palms and Soles
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
57
|
|
0.310 |
None |
1.000 |
2 |
|
2003 |
2010 |
Stevens-Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
30
|
14
|
0.310 |
None |
1.000 |
1 |
1
|
2009 |
2018 |
Mycoplasma-Induced Stevens-Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Precursor B-cell lymphoblastic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Drug-Induced Stevens Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
1
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
mixed gliomas
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
84
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
84
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Burkitt Lymphoma
|
disease |
Neoplasms; Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
36
|
5
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
PSORIASIS SUSCEPTIBILITY 1
|
disease |
|
Finding
|
1
|
|
0.300 |
limited |
|
0 |
|
|
|
HIV Coinfection
|
disease |
Infections; Immune System Diseases
|
Disease or Syndrome
|
103
|
|
0.300 |
None |
|
0 |
|
|
|